Patient pharmacy benefit tool re cost of prescription drugs: grants to develop and implement; special education, UW System, and TCS funding provision -
AB549Patient pharmacy benefit tool re cost of prescription drugs: grants to develop and implement -
SB554Pharmacist training on dispensing opioid antagonists required [Sec. 2879, 2882, 9138 (2)] [original bill only] -
AB68Pharmacist training on dispensing opioid antagonists required [Sec. 2879, 2882, 9138 (2)] -
SB111Pharmacists authorized to extend a prescription order: 2019 WisAct 185 provisions extended -
AB1Pharmacists authorized to extend a prescription order: 2020 public health emergency provision extended -
SB149Pharmacists authorized to extend a prescription order, expires December 31, 2021 -
AB31Pharmacy benefit manager license and regulation requirements; pharmacy requirements re drug substitution, listing of retail prices and generic and corresponding brand name drugs, and notification of changes to prescription benefits [Sec. 730, 733, 734, 1117, 2163, 2397, 2885-2887, 2906, 2911, 2924, 2926, 2954, 2955, 2959-2963, 2965, 2987-3009, 9123 (1), 9323 (1), 9423 (1)] [original bill only] -
AB68Pharmacy benefit manager license and regulation requirements; pharmacy requirements re drug substitution, listing of retail prices and generic and corresponding brand name drugs, and notification of changes to prescription benefits [Sec. 730, 733, 734, 1117, 2163, 2397, 2885-2887, 2906, 2911, 2924, 2926, 2954, 2955, 2959-2963, 2965, 2987-3009, 9123 (1), 9323 (1), 9423 (1)] -
SB111Pharmacy benefit manager licensure requirements and regulations; cost-sharing limitation; specified disclosures to customers; notification of drug substitution -
AB7Pharmacy benefit manager licensure requirements and regulations; cost-sharing limitation; specified disclosures to customers; notification of drug substitution -
SB3Pharmacy technicians authorized to administer vaccines; any health care provider authorized to administer vaccines may supervise pharmacy students administering vaccines [A.Amdt.1: adds administration of specified drugs for adverse reactions; S.Amdt.1: adds use of the title “pharmacist” provision] -
AB4Prescription Drug Affordability, Office of, in the OCI: funding for establishment of and FTE positions -
AB556Prescription Drug Affordability, Office of, in the OCI: funding for establishment of and FTE positions -
SB578Prescription Drug Affordability Review Board created -
AB544Prescription Drug Affordability Review Board created [Sec. 67, 88, 2914-2917, 9123 (8), 9423 (4)] [original bill only] -
AB68Prescription Drug Affordability Review Board created [Sec. 67, 88, 2914-2917, 9123 (8), 9423 (4)] -
SB111Prescription Drug Affordability Review Board created -
SB540Prescription drug cost reporting by manufacturers: requirements established -
AB512Prescription drug cost reporting by manufacturers: requirements established -
SB499Prescription drug cost reporting requirements [Sec. 2953, 2967, 9123 (3)] [original bill only] -
AB68Prescription drug cost reporting requirements [Sec. 2953, 2967, 9123 (3)] -
SB111Prescription drug importation program established [Sec. 2912, 9123 (2)] [original bill only] -
AB68Prescription drug importation program established; JCF approval required -
AB548Prescription drug importation program established [Sec. 2912, 9123 (2)] -
SB111Prescription drug importation program established; JCF approval required -
SB539Prescription drug limits prohibition enacted in 2019 WisAct 185 reinstated -
AB1Prescription drug limits prohibition enacted in 2019 WisAct 185 reinstated, period specified -
AB31Prescription drug limits prohibition enacted in 2019 WisAct 185 reinstated, period specified -
SB130Prescription Drug Monitoring Program: certain exemption to review of patient’s records repealed -
AB430Prescription Drug Monitoring Program: certain exemption to review of patient’s records repealed -
SB407Prescription drug payments made by enrollee applied to health insurance out-of-pocket maximum or cost-sharing requirements -
AB184Prescription drug payments made by enrollee applied to health insurance out-of-pocket maximum or cost-sharing requirements -
SB215Reckless handling of a vaccine or drug rendering it ineffective or unusable made a felony; JRCCP may report -
AB225Reckless handling of a vaccine or drug rendering it ineffective or unusable made a felony; JRCCP may report [S.Amdt.1: "reckless handling" changed to "intentional destruction"] -
SB242State prescription drug purchasing entity study -
AB558State prescription drug purchasing entity study [Sec. 9123 (6)] -
SB111State prescription drug purchasing entity study [Sec. 9123 (6)] [original bill only] -
AB68State prescription drug purchasing entity study -
SB551Step therapy protocol for certain cancer drugs: insurer, pharmacy benefit manager, or utilization review organization prohibited from requiring -
AB745Step therapy protocol for certain cancer drugs: insurer, pharmacy benefit manager, or utilization review organization prohibited from requiring -
SB716Tax revisions re obsolete statutory references, electronic assessment rolls, Internet equipment in the broadband market, property tax assessment objections, and sales tax exemptions for insulin, farm-raised fish, and patient health care records (remedial legislation suggested by DOR) -
AB1033Tax revisions re obsolete statutory references, electronic assessment rolls, Internet equipment in the broadband market, property tax assessment objections, and sales tax exemptions for insulin, farm-raised fish, and patient health care records (remedial legislation suggested by DOR) -
SB1020Third-party logistics providers: optional license created; Pharmacy Examining Board duties -
AB1Third-party logistics providers: optional license created; Pharmacy Examining Board duties -
SB144Third-party logistics providers: optional license created; Pharmacy Examining Board duties [A.Amdt.1: applicability provision modified] -
AB120Third-party logistics providers: optional license created; Pharmacy Examining Board duties -
SB163Third-party logistics providers: optional license created; Pharmacy Examining Board duties and interim license -
AB31Unfair drug pricing practices and fraudulent drug advertising prohibitions [Sec. 1567, 1570] [original bill only] -
AB68Unfair drug pricing practices and fraudulent drug advertising prohibitions [Sec. 1567, 1570] -
SB111Unfair Sales Act exemption for items that are qualified medical expenses -
AB358Unfair Sales Act exemption for items that are qualified medical expenses -
SB357Value-based diabetes medication pilot program [Sec. 2908] [original bill only] -
AB68Value-based diabetes medication pilot program [Sec. 2908] -
SB111Value-based diabetes medication pilot project established -
AB551Value-based diabetes medication pilot project established -
SB550Wisconsin drug repository program revisions, study required -
AB546Wisconsin drug repository program revisions, study required [Sec. 2595, 9119 (4)] [original bill only] -
AB68Wisconsin drug repository program revisions, study required [Sec. 2595, 9119 (4)] -
SB111Wisconsin drug repository program revisions, study required -
SB577Butane extraction used to manufacture marijuana or separate plant resin from marijuana plants: penalty revisions; JRCCP may report -
AB440Butane extraction used to manufacture marijuana or separate plant resin from marijuana plants: penalty revisions; JRCCP may report -
SB440Drug paraphernalia definition excludes materials used to test for fentanyl [Sec. 3398] [original bill only] -
AB68Drug paraphernalia definition excludes materials used to test for fentanyl [Sec. 3398] -
SB111Fentanyl and fentanyl analogs: felony penalties for manufacture, distribution, delivery, or possession revised; JRCCP may report -
AB357Fentanyl and fentanyl analogs: felony penalties for manufacture, distribution, delivery, or possession revised; JRCCP may report -
SB352Fentanyl testing strips excluded from definition of drug paraphernalia -
AB619Fentanyl testing strips excluded from definition of drug paraphernalia -
SB600Immunity from prosecution for controlled substance possession for person aiding an overdose victim: 2017 WisAct 33 expired provisions made permanent [Sec. 3382-3384] [original bill only] -
AB68Immunity from prosecution for controlled substance possession for person aiding an overdose victim: 2017 WisAct 33 expired provisions made permanent [Sec. 3382-3384] -
SB111Immunity from prosecution for person aiding a person experiencing a drug overdose: providing assistance as soon as reasonably possible condition added -
AB921Immunity from prosecution for person aiding a person experiencing a drug overdose: providing assistance as soon as reasonably possible condition added -
SB878Indoor smoking ban applied to electronic smoking devices and marijuana; “smoking” definition revised -
AB1123Indoor smoking ban applied to electronic smoking devices and marijuana; “smoking” definition revised -
SB1031Legalizing recreational marijuana; JRCCP may report; JSCTE appendix report -
AB846Legalizing recreational marijuana; JRCCP may report; JSCTE appendix report -
SB545Marijuana possession of not more than 10 grams: penalty reduced to a forfeiture, local government ordinance preemption; deposit in lieu of court appearance provision; JRCCP may report -
AB130Marijuana possession of not more than 10 grams: penalty reduced to a forfeiture, local government ordinance preemption; deposit in lieu of court appearance provision; JRCCP may report -
SB164Marijuana possession penalties revised, ordinance and law enforcement provisions; limited liability for employer that does not require drug testing as condition of employment; JRCCP may report -
AB812Marijuana possession penalties revised, ordinance and law enforcement provisions; limited liability for employer that does not require drug testing as condition of employment; JRCCP may report -
SB790Marijuana: recreational use legalized, permit required; portion of excise tax revenue deposited in community reinvestment fund to promote diversity and equity; medical marijuana registry created; JLC study [Sec. 265, 266, 292, 317, 411, 467, 498, 502, 610, 888, 959, 1053, 1085, 1086, 1112, 1136, 1404, 1433, 1563-1566, 1732, 1743, 1796, 1797, 1811, 1893, 1894, 1909, 2269, 2291, 2292, 2649, 2829, 3367-3381, 3389, 3391-3397, 3404, 3405, 3417-3420, 3441, 9128 (2)] [original bill only] -
AB68Marijuana: recreational use legalized, permit required; portion of excise tax revenue deposited in community reinvestment fund to promote diversity and equity; medical marijuana registry created; JLC study [Sec. 265, 266, 292, 317, 411, 467, 498, 502, 610, 888, 959, 1053, 1085, 1086, 1112, 1136, 1404, 1433, 1563-1566, 1732, 1743, 1796, 1797, 1811, 1893, 1894, 1909, 2269, 2291, 2292, 2649, 2829, 3367-3381, 3389, 3391-3397, 3404, 3405, 3417-3420, 3441, 9128 (2)] -
SB111Medical cannabis: DHS to establish registry for specified medical conditions or treatments and issue ID cards; producer, processor, or dispensary to obtain license from DATCP, conditions and fee provisions; discrimination in employment and licensing prohibitions; medical use defense to THC-related prosecutions and forfeiture actions for registered persons; JRCCP may report -
AB1063Medical cannabis: DHS to establish registry for specified medical conditions or treatments and issue ID cards; producer, processor, or dispensary to obtain license from DATCP, conditions and fee provisions; discrimination in employment and licensing prohibitions; medical use defense to THC-related prosecutions and forfeiture actions for registered persons; JRCCP may report -
SB1035Medical marijuana program created, license provisions; Medical Marijuana Regulatory Commission created and attached to DOR; excise tax, criminal provisions, Prescription Drug Monitoring Program, fair employment law, UI, and WC provisions; JRCCP may report -
AB1067Medical marijuana program created, license provisions; Medical Marijuana Regulatory Commission created and attached to DOR; excise tax, criminal provisions, Prescription Drug Monitoring Program, fair employment law, UI, and WC provisions; JRCCP may report -
SB1034Methamphetamine addiction treatment grants -
AB844Methamphetamine addiction treatment grants -
SB1032
